KALA BIO, Inc. (0JQ2.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.48M |
| Enterprise Value | -3.08M |
| P/E Ratio | -0.04 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 6.72 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.75 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.95 |
| Return On Equity | -2.22 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -317,000 |
| EBITDA | -42.09M |
| Net Income | -26.98M |
| Diluted EPS | -165.5 |
Balance Sheet
| Total Cash | 7.23M |
| Total Cash/Share | 0.1 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 6.88 |
| Book Value Per Share | 0.12 |
Price History
| 52-Week Change | -99.82 |
| 52-Week High | 19.48 |
| 52-Week Low | 0.83 |
| Moving Average 50 Days | 7.08 |
| Moving Average 200 Days | 11.17 |
Statistics
| Average Volume | 320 |
| Shares Outstanding | 140,421 |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
| Last Split Date | May 12, 2026 |
AD
